Assessment of cholecalciferol and antihypertensive therapy concominant use in people with arterial hypertension

L.V. Yankouskaya, V.A. Snezhitskiy, S.A. Lyalikov, L.V. Kezhun

Abstract


Background. The purpose of the study was to assess the effect of cholecalciferol intake at a daily dose of 2,000 IU on the serum level of 25(ОН)D total and blood pressure (BP) against the background of antihypertensive therapy in people with arterial hypertension(AH) stage II. Results. It was found that intake of diuretics (hydrochlorothiazide at a dose of 12.5–25.0 mg or indapamide 1.5 mg) as part of combination antihypertensive therapy influenced the dynamics of serum 25(OH)D (F = 5.35; p = 0.02) and its level (F = 11.8; p = 0.0009). Dynamic SBP value was highest (–27.4 ± 17.9) in the group receiving a diuretic and cholecalciferol, which was significantly (p < 0.001) different from the comparison group. In the same group, we established a correlation relationship between dynamic SBP and length of cholecalciferol intake (R = 0.42; p = 0.023). A significant influence of both cholecalciferol (F = 4,1; p = 0.046), and diuretics (F = 14.3; p = 0.0003) on dynamic SBP was established. Conclusions. Thiazide/thiazide-like diuretics negatively influenced the improvement of serum 25(OH)D level. The combined use of cholecalciferol and diuretic at a dose of 2000 IU/day in the treatment of patients with AH II degree allowed to obtain the greatest hypotensive effect on SBP without the risk of vitamin D overdosing in the body.


Keywords


артериальная гипертензия; холекальциферол; антигипертензивная терапия; диуретики

Full Text:

PDF

References


Płudowski P, et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe — recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 2013;64(4):319-27. PMID: 24002961.

Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007 Jul;20(7):713-9. doi: 10.1016/j.amjhyper.2007.01.017.

Forouhi NG, et al. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective study 1990-2000. Diabetes. 2008 Oct;57(10):2619-25. doi: 10.2337/db08-0593.

Smotkin-Tangorra M, et al. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab. 2007;20:817-23. PMID: 17849744.

Gannage-Yared MH, et al. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009;160:965-71. doi: 10.1530/EJE-08-0952.

Snezhitskiy VA, Yankouskaya LV, Povorozniuk VV, et al. Vitamin D deficiency/insufficiency among residents of the Western Region of Belarus suffering from cardiovascular pathology. Standardy Medyczne. Pediatria. 2012;5:577-82. (In Russian).

Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283 537 participants. Eur J Epidemiol. 2013;28(3):205-21. doi: 10.1007/s10654-013-9790-2.

Beveridge LA. Effect of Vitamin D Supplementation on Blood Pressure A Systematic Review and Meta-analysis Incorporating Individual Patient Data. JAMA Intern Med. 2015 May;175(5):745-54. doi: 10.1001/jamainternmed.2015.0237.

Sugden JA, Davies JI, Witham MD, et al. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008 May;25(3):320-5. doi: 10.1111/j.1464-5491.2007.02360.x.

Grassi G, Cifkova R, Laurent S, et al. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. European Heart Journal. 2011;32:218-25. doi: 10.1093/eurheartj/ehq394.

Mancia G. ESH/ESC Guidelines for the management of arterial hypertension 2013. Journal of Hypertension. 2013 July;31(7):1281-1357. doi: 10.1097/01.hjh.0000431740.32696.cc.

Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009 Oct;27(10):1948-54. doi: 10.1097/HJH.0b013e32832f075b.

Kunutsor SK. Vitamin D and high blood pressure: causal association or epiphenomenon? Eur J Epidemiol. 2014;29:1-14. doi: 10.1007/s10654-013-9874-z.

Li Y.C. Vitamin D: a negative endocrine regulator of the reninangiotensin system and blood pressure. J Ster Biochem Molec Biol. 2004 May;89-90(1-5):387-92. doi: 10.1016/j.jsbmb.2004.03.004.

Kong J. Targeted vitamin D receptor expression in juxtaglomerular cells supresses rennin expression independent of parathyroid hormone and calcium. Kidney International. 2008 Dec;74(12):1577-81. doi: 10.1038/ki.2008.452.

Kezhun LV, Yankouskaya LV. Plasma renin activity, endothelial function, and vitamin d status in women with hypertension in premenopausal and early postmenopausal periods. Zhurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta. 2014;4(48):37-42. (In Russian).

Kezhun LV, Yankouskaya LV. Role of renin-angiotensin-aldosterone system and vitamin d in development of arterial hypertension in perimenopausal women. Zhurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta. 2013;1(41):14-7. (In Russian).

Chen WR, Liyu ZY, et al. Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: A randomized placebo-controlled trial. Atherosclerosis. 2014;235(1):102-9. doi: 10.1016/j.atherosclerosis.2014.04.011.

Forman JР. Plasma 25-hydroxy vitamin D levels and risk of incident hуреrtеnsiоn. Hypertension. 2007;49(5):1063-9. doi: 10.1161/HYPERTENSIONAHA.107.087288.




DOI: https://doi.org/10.22141/2224-1507.7.2.2017.108695

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 PAIN. JOINTS. SPINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru